FDA Approved: BRINEURA — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approves a supplemental application for Brineura (cerliponase alfa) from BioMarin Pharmaceutical Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Late-infantile Neuronal Ceroid Lipofuscinosis Type

Drugs mentioned

• BRINEURA (cerliponase alfa)

Snippet

SUPPL AP for BRINEURA (CERLIPONASE ALFA)